RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers-Reference-Cited by-同舟云学术

RNAi-based therapeutics for lung cancer: biomarkers, microRNAs, and nanocarriers

Published:2018-09-21 Issue:10 Volume:15 Page:965-982
ISSN:1742-5247
Container-title:Expert Opinion on Drug Delivery
language:en
Short-container-title:Expert Opinion on Drug Delivery

Author:

Magalhães Mariana¹²,Alvarez-Lorenzo Carmen³^ORCID,Concheiro Angel³^ORCID,Figueiras Ana¹²,Santos Ana Cláudia¹²,Veiga Francisco¹²

Affiliation:

1. Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal

2. REQUIMTE/LAQV, Group of Pharmaceutical Technology, Faculty of Pharmacy, University of Coimbra, Coimbra, Portugal

3. Departamento de Farmacología, Farmacia y Tecnología Farmacéutica, R+D Pharma Group (GI-1645), Facultad de Farmacia and Health Research Institute of Santiago de Compostela (IDIS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain

Funder

Portuguese Foundation for Science and Technology (FCT) and the European Community Fund (FEDER) through the COMPETE2020 program

Portugal National Funds (FCT/MEC, Fundação para a Ciência e Tecnologia/Ministério da Educação e Ciência) and co-financed by European Union

Portuguese Foundation for Science and Technology

MINECO and Agencia Estatal de Investigación (AEI) of Spain

Publisher

Informa UK Limited

Subject

Pharmaceutical Science

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425247.2018.1517744

Reference162 articles.